Jiawei Zou

No ORCID on file · 1 paper in corpus
2025
·doi:10.1101/2025.07.08.663664

Pancreatic cancer (PC) patient-derived organoids (PDOs) faithfully recapitulate therapeutic responses but face clinical translation barriers, including high costs and technical complexity. To address these problems and the lack of framework…